Multiple Sclerosis is an enigmatic diseases that has strong geographical prevalence. In fact, a majority of the cases appear in the northern hemisphere. Theories point to a lack of sunlight in the northern hemisphere as a correlating factor to the development of Multiple Sclerosis. Scholars believe that myelin sheath layers is comparable to the skin, in that it protects the body from harmful UV rays. More time spent outdoors, during brain development, correlates to a thicker myelin sheath layer. In studies with identical twins, the only corroborating source of one's development of Multiple Sclerosis was the respective decreased amount of time in sunlight. Further studies illustrate that individuals from equatorial regions of the world who move from their respective locale to an area further north tend to develop Multiple Sclerosis at accelerated rates when compared to the native populous.
Although Multiple Sclerosis is generally thought of as an auto-immune disease, recent work indicates that it could be a result of a vascular disorder that allows immune cells and other toxic substances to leak out of damaged capillaries to attack the surrounding nerve cells. When leaked from blood vessels fibrinogen has a tendency to attach to myelin sheath cells. The attachment of fibrinogen to the myelin sheath cells could lead to an auto-immune response. The subsequent antibody release dissolves the myelin sheath layer, leading to the symptoms of Multiple Sclerosis. Pregnant women will often experience a remission of symptoms of Multiple Sclerosis due to the large amount of growth factors in the body during pregnancy. An agent such as Zhittya Genesis Medicine's drug, that can heal and reverse vascular disorder, may be an effective treatment for Multiple Sclerosis, by healing or establishing new microvasculature in affected regions of the central nervous system.
This is our video explaining our in-depth theory behind treating Multiple Sclerosis through FGF-1.